Disease Status and Pubertal Stage Predict Improved Growth in Antitumor Necrosis Factor Therapy for Pediatric Inflammatory Bowel Disease. (2017)

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1097/mpg.0000000000001379

PubMed Identifier: 27657882

Publication URI: http://europepmc.org/abstract/MED/27657882

Type: Journal Article/Review

Volume: 64

Parent Publication: Journal of pediatric gastroenterology and nutrition

Issue: 1

ISSN: 0277-2116